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In Brief
Data-independent acquisition
proteomics was used to study
proteome changes of naive hu-
man neutrophils in rare mono-
genic diseases affecting their
functions. Neutrophils of patients
with mutations in the neutrophil
elastase gene ELANE demon-
strated global proteome dys-
regulation, whereas chronic
granulomatous disease and leu-
kocyte adhesion deficiency had
modest effects on the respective
neutrophil proteomes. Proteom-
ics then guided targeted genetic
assays to resolve two clinical
cases with undetermined genetic
causes, highlighting the useful-
ness of mass spectrometry-
based clinical diagnostics.
Graphical Abstract
Highlights
• Data-independent acquisition proteomics analysis of naive neutrophils from patients with rare mono-
genic diseases.
• Proteomics analysis helps guide targeted genetic diagnostics of patients for which routine clinical
diagnostics proved inconclusive.
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Proteome Analysis of Human Neutrophil
Granulocytes From Patients With Monogenic
Disease Using Data-independent Acquisition*□S
Piotr Grabowski‡¶¶¶, Sebastian Hesse§¶¶¶, Sebastian Hollizeck§, Meino Rohlfs§,
Uta Behrends, Roya Sherkat**, Hannah Tamary‡‡, Ekrem U¨nal§§, Raz Somech¶¶,
Tu¨rkan Patırog˘lu§§, Stefan Canzar, Jutte van der Werff Ten Bosch‡‡‡,
Christoph Klein§***¶¶¶, and Juri Rappsilber‡¶§§§¶¶¶
Neutrophil granulocytes are critical mediators of innate
immunity and tissue regeneration. Rare diseases of neu-
trophil granulocytes may affect their differentiation and/or
functions. However, there are very few validated diagnos-
tic tests assessing the functions of neutrophil granulo-
cytes in these diseases. Here, we set out to probe omics
analysis as a novel diagnostic platform for patients with
defective differentiation and function of neutrophil gran-
ulocytes. We analyzed highly purified neutrophil granulo-
cytes from 68 healthy individuals and 16 patients with rare
monogenic diseases. Cells were isolated from fresh ve-
nous blood (purity >99%) and used to create a spectral
library covering almost 8000 proteins using strong cation
exchange fractionation. Patient neutrophil samples were
then analyzed by data-independent acquisition proteom-
ics, quantifying 4154 proteins in each sample. Neutrophils
with mutations in the neutrophil elastase gene ELANE
showed large proteome changes that suggest these mu-
tations may affect maturation of neutrophil granulocytes
and initiate misfolded protein response and cellular stress
mechanisms. In contrast, only few proteins changed in
patients with leukocyte adhesion deficiency (LAD) and
chronic granulomatous disease (CGD). Strikingly, neutro-
phil transcriptome analysis showed no correlation with
its proteome. In case of two patients with undetermined
genetic causes, proteome analysis guided the targeted ge-
netic diagnostics and uncovered the underlying genomic
mutations. Data-independent acquisition proteomics may
help to define novel pathomechanisms in neutrophil
diseases and provide a clinically useful diagnostic
dimension. Molecular & Cellular Proteomics 18: 760–
772, 2019. DOI: 10.1074/mcp.RA118.001141.
Neutrophil granulocytes constitute the most abundant pop-
ulation of nucleated cells in human blood. Whereas their role
in defense against microbes has been known for more than a
century, their sophisticated roles in tissue remodeling, cancer
and chronic inflammation has emerged only recently (1, 2).
Rare diseases of neutrophil granulocytes may affect their
differentiation and/or function. Severe congenital neutropenia
(SCN)1 comprises a heterogeneous group of monogenic dis-
orders characterized by aberrant premature apoptosis of my-
eloid progenitor cells (3). Chronic granulomatous disease
(CGD) results from mutations in one out of five subunits of the
NADP-oxidase complex (4). Leukocyte adhesion deficiency
(LAD) causes aberrant transendothelial migration of neutrophil
granulocytes because of integrin defects (5).
In striking contrast to their prominent role in health and
disease, there are very few validated diagnostic tests assess-
ing the function of neutrophil granulocytes. Although quanti-
tative studies (i.e. differential blood counts) are among the
most common laboratory tests, validated qualitative studies
are virtually absent, except for measurement of NADPH-oxi-
dase activity for CGD and expression of defined cell surface
markers to diagnose LAD.
Genetic sequencing assays, based on defined panels, ex-
ome, or whole genome sequencing are the gold standard for
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the diagnosis of monogenic diseases, yielding conclusive re-
sults in up to 25–50% of patients (6, 7). To capture the
complexities of diseases and to increase the diagnostic yield,
additional omics technologies and data integration may be
useful. This has recently been shown for strategies associat-
ing genome and RNA-sequencing in rare neuromuscular
diseases (8, 9). We hypothesized that in-depth proteome-
analysis may also provide additional cues for diagnosis of
monogenic diseases, such as rare defects of neutrophil gran-
ulocytes. In the past, several laboratories have published data
on the proteome of healthy neutrophil granulocytes (10–23),
however all but one (10) quantified significantly fewer proteins
compared with our study. We here systematically analyze
proteome changes in neutrophils from patients with different
monogenic diseases and demonstrate the usefulness of next-
generation proteomics for guiding clinical genetic diagnostics.
EXPERIMENTAL PROCEDURES
Experimental Design and Statistical Rationale—The total
number of analyzed neutrophil samples was 84 (68 healthy
controls and 16 patients). The patient samples were meas-
ured without replication. The size of the healthy control group
allowed to average out biological variation. The rationale for
choosing the large healthy control group was that it allowed to
better estimate parameters of the Gaussian curves fitted to
protein expression profiles for outlier detection in the two
unclear clinical cases. Differential protein expression analysis
was performed with limma R package (24), while blocking for
batch effects.
Patient Cohort—Patients were recruited from pediatric cen-
ters in Germany (LMU University, Dr. von Hauner Children’s
Hospital; and TU University, Department of Pediatrics), Turkey
(Erciyes University, Fevzi Mercan Children’s Hospital, Kayseri),
Iran (Isfahan University, Imam Hossein Children’s Hospital, Is-
fahan) and Israel (Schneider Children’s Medical Center of Israel,
Tel Aviv). Informed consent was given by the parents or legal
guardians in accordance with the Declaration of Helsinki and
European legislation. Children were asked for their informed
assent. The study was approved by the LMU Munich ethics
committee as well as ethics boards of local clinical institutions.
Extraction and Purification of Neutrophils—Blood was
drawn from patients and healthy donors into EDTA-containing
collection tubes (clinical standard tubes for anticoagulation,
Sarstedt, Nu¨mbrecht, Germany, 04.1915.100) and immedi-
ately processed within a 4 h time window. Neutrophils were
isolated with the MACSexpress human neutrophil isolation kit
(Miltenyi, Bergisch Gladbach, Germany, 130-104-434) ac-
cording to the vendor’s protocol. For total erythrocyte deple-
tion the MACSxpress Erythrocyte Depletion Kit (Miltenyi, 130-
098-196) was used according to the vendor’s protocol. After
isolation, neutrophils were twice washed in PBS (Gibco, Pais-
ley, Scotland, UK, 14190250), microscopically counted in a
hemocytometer and divided into aliquots of 1  106 or 2.5 
105 cells. A cytospin stained with May-Grunwald Giemsa for
cell purity control was prepared when possible. After pelleting,
the supernatant was removed and 5 l of 25x protease inhibitor
was added (Roche, Penzberg, Germany, 04693159001). Cells
were then frozen in a80 °C freezer before being transferred to
storage in liquid nitrogen until final proteome preparation.
Neutrophil Sample Preparation for Mass Spectrometry—
Purified neutrophil samples were processed with the Filter-
Aided Sample Preparation (FASP) method as follows: 106
cells were lysed using 50 l of SDS lysis buffer (0.5% SDS, 0.1
M DTT in 0.1 M Tris-HCl pH 7.6) and sonicated for 30 s using
a Branson Ultrasonics 250A analog sonifier (10% duty cycle,
energy level 1). Samples were then heated for 5 min at 95 °C
in a heating block. Subsequently, 150 l of UA buffer (8 M urea
in 0.1 M Tris-HCl pH 8.5) were added to the samples to a total
volume of 200 l, loaded onto 0.5 ml Microcon 30 kDa-cutoff
Ultracel membrane filters (Merck, Germany, catalog number
MRCF0R030) and spun down in an Eppendorf 5418 centrifuge
for 20 min at 14,000 rcf. Next, 200 l of UA buffer was added
and the centrifugation repeated. Subsequently, 50 l of IAA
buffer (0.05 M iodoacetamide in UA buffer) were added to the
filters and incubated in darkness for 20 min at room tempera-
ture. Next, two washing steps using 150 l and 200 l of UA
buffer were performed, each time spinning down the samples
for 20 min at 14,000 rcf. As a final washing step, the samples
were washed twice with 200 l of ABC buffer (50 mM ammo-
nium bicarbonate in ddH2O) and spun down as described
above.
The filters with washed samples were then transported to
new collector tubes and MS-grade trypsin (Thermo Fisher,
Germany, catalogue number 90057) in digestion buffer (1 M
urea in 0.1 M Tris-HCl 8.5) was added in 1:100 ratio. The filters
were wrapped in parafilm to prevent drying and placed in a
wet chamber for overnight digestion at 37 °C.
Finally, the samples were spun down for 15 min at 14,000
rcf, 50 l of ABC buffer were added to the filters and the
centrifugation step repeated. The samples were then acidified
to pH 2.5 using 20% TFA (trifluoroacetic acid). The peptide
yield was estimated using Thermo Fisher NanoDrop 2000c.
The samples were cleaned-up and desalted using a C18-
StageTip approach as described in (25) and stored at20 °C.
Generation of Spectral Library: SCX Chromatography—To
create a comprehensive neutrophil spectral library, selected
healthy donor and patient peptide samples were eluted from
StageTips using 80% acetonitrile (ACN) in 0.1% formic acid,
1 The abbreviations used are: SCN, severe congenital neutropenia;
ABC, ammonium bicarbonate; CAN, acetonitrile; ANC, absolute neu-
trophil counts; CGD, chronic granulomatous disease; DDA, data-de-
pendent acquisition; DIA, data-independent acquisition; DTT, dithio-
threitol; EDTA, ethylenediaminetetraacetic acid; FASP, filter-aided
sample prep; FDR, false discovery rate; GO, gene ontology; IAA,
iodoacetamide; LAD, leukocyte adhesion deficiency; NBT, nitroblue
tetrazolium; PBS, phosphate-buffered saline; PCA, principal compo-
nent analysis; PCC, Pearson correlation coefficient; SCX, strong cat-
ion exchange; SDS, sodium dodecyl sulfate; TFA, trifluoroacetic acid.
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dried in Eppendorf Concentrator plus 5305, reconstituted in
SCX buffer A (5 mM K2HPO4 in 10% ACN) and pooled. 100 g
of pooled peptides were separated on a Shimadzu LC-20AD
HPLC system using a PolyLC PolySULFOETHYL-A SCX col-
umn (100  2.1 mm, 3 m beads, 300 Å pores) with a 12 min
nonlinear gradient of SCX buffer B (1 M KCl, 5 mM K2HPO4 in
10% ACN) while collecting fractions every 15 s. The fractions
were then concentrated, reconstituted in 0.1% TFA and de-
salted using C18-StageTips. Lower complexity fractions were
pooled together prior to mass spectrometric analysis.
Generation of Spectral Library: Data-dependent Acquisi-
tion—The spectral library SCX fractions were analyzed on
Thermo Fisher QExactive HF mass spectrometer coupled to a
Dionex UltiMate 3000 HPLC system using a 50 cm C-18
Thermo Fisher EasySpray column (catalog number ES803),
heated to 50 °C. Roughly 2 g of peptides was loaded onto
the column for each run. All samples contained spiked-in iRT
peptides (Biognosys, Switzerland, catalog number Ki-3002-2)
for retention-time alignment.
A 135-min gradient was used as follows: the flow rate was
set to 300 nl/min, start at 2% buffer B (80% ACN in 0.1% FA)
with a linear increase to 35% B for 90 min followed by a linear
increase to 41% until 102 min and to 99% B until 104 min with
a hold at 99% B until 120 min for washing. The gradient was
then reduced to 2% B at 120 min and held at 2% for 15 min
for column re-equilibration.
A Top10 DDA method was used as follows: 1 full MS1 scan
between 350 and 1300 m/z at resolution of 120,000, with AGC
target of 3e6, maximum injection time (IT) of 50 ms and a
default charge state of 2. Ten most intense peaks were se-
lected for MS2 fragmentation using resolution 15,000, AGC
target of 1e5 and a maximum IT of 80 ms. The isolation
window was set to 1.6 m/z, fixed first mass to 100 m/z and a
normalized collision energy (NCE) to 30. Additionally, a dy-
namic exclusion of 30 s was set.
Generation of Spectral Library: Raw Data Processing—Peak
lists obtained from DDA MS/MS spectra were identified using
X! Tandem Vengeance (2015.12.15.2) (26), Andromeda ver-
sion 1.5.3.4 (27), MS Amanda version 1.0.0.7501 (28), MS-
GF version Beta (v10282) (29) and Comet version 2016.01
rev. 3 (30). The search was conducted using SearchGUI ver-
sion 3.2.19 (31).
Protein identification was conducted against a complete
Uniprot SwissProt human protein sequence database (state
on June 27, 2016). The decoy sequences were created by
reversing the target sequences in SearchGUI. The identifica-
tion settings were as follows: trypsin, specific, with a maxi-
mum of 2 missed cleavages. 10.0 ppm as MS1 and 20 ppm as
MS2 tolerances; fixed modifications: carbamidomethylation
of C (57.021464 Da); variable modifications: acetylation of
protein N-term (42.010565 Da), oxidation of M (15.994915
Da); fixed modifications during refinement procedure: carb-
amidomethylation of C (57.021464 Da); variable modifica-
tions during refinement procedure: pyrolidone from E
(–18.010565 Da), pyrolidone from Q (–17.026549 Da), pyroli-
done from carbamidomethylated C (–17.026549 Da). Peptides
and proteins were inferred from the spectrum identification
results using PeptideShaker version 1.16.11 (32). Peptide
Spectrum Matches (PSMs), peptides and proteins were vali-
dated at a 1% False Discovery Rate (FDR) estimated using the
decoy hit distribution. All engine-specific settings were set
kept as default. The list of peptides identified in this study can
be found in the supplemental Table S6.
Data-independent Acquisition of Neutrophil Proteomes—
The data-independent acquisitions were performed on the
same equipment as the spectral library DDA measurements
using the exact same chromatography conditions. Each pa-
tient sample was measured once because of the size of the
cohort. All the samples contained spiked-in iRT peptides
(Biognosys, catalogue number Ki-3002–2) for retention-time
alignment. The mass spectrometry settings were as follows:
one MS1 scan was performed between 350 and 1300 m/z at
resolution of 120,000, AGC target of 5e6 and a maximum IT of
100 ms, followed by ten 12.5 m/z MS2 windows, ten 37.5 m/z
MS2 windows and a final single 450 m/z MS2 window (21
MS2 windows total). In case of all the MS2 windows the
resolution was set to 30,000, AGC target to 1e6, maximum IT
to “auto” and the collision energy to 30. Both MS1 and MS2
scans were recorded in profile mode. The DIA method resulted
in a median of 7 data points per peak. The mass spectrometry
proteomics data have been deposited to the ProteomeXchange
Consortium via the PRIDE (33) partner repository with the data
set identifier PXD010701.
Protein Identification and Quantification—Biognosys Spec-
tronaut 11 was used for DIA search and protein quantification.
The DIA raw files were converted into HTRMS format using
Biognosys HTRMS converter.
Our sample-specific SCX spectral library containing 119193
precursors, 87757 peptides and 7977 proteins, was imported.
Minimum of 3 up to 6 best fragments per peptide were used.
The DIA search and quantification were performed with the
following settings: using precision iRT and nonlinear iRT cal-
ibration, MS1 and MS2 mass tolerance strategy were set to
“Dynamic,” XIC RT extraction window was set to “Dynamic.”
Precursor FDR was set to 1% and protein FDR was set to 5%
(using decoy method set to “inverse”). Data filtering was set to
“Qvalue percentile 0.5,” cross-run normalization was set to
“Qvalue complete.” Peptide quantification was performed us-
ing mean precursor quantity (using up to 3 top precursors)
and the area under the MS2 signal. Protein quantification was
performed using mean peptide quantity (using up to 3 top
peptides per protein). Protein inference was set to automatic.
All settings for our Spectronaut analyses can be found in the
Spectronaut experiment file (.sne) uploaded to the PRIDE
archive with raw files.
As a final filtering step, known contaminants according to
MaxQuant (34) were removed from the list of quantified
proteins.
DIA Proteomics Aids Clinical Genetic Diagnostics
762 Molecular & Cellular Proteomics 18.4
 by guest on A
pril 1, 2019
http://w
w
w
.m
cponline.org/
D
ow
nloaded from
 
Differential Protein Expression Analysis—Limma R package
(24) was used to perform differential protein expression anal-
ysis using empirical Bayes moderation. The log2-transformed
expression values were normally distributed. In order to in-
crease the power of the analysis, the extra term (sample
processing date) was added to the model for blocking as a
mean of batch-effect control. The expression matrix used in
this analysis was not processed by the ComBat algorithm.
Only proteins identified by two or more peptides were used
for differential abundance testing. Hits with Benjamini-Hoch-
berg P-adjusted value 0.01 were considered statistically
significant.
Gaussian Model Fitting for Protein Expression Anomaly De-
tection—Log2-transformed protein expression values in
healthy donors were used to fit a Gaussian model for each
protein using R package MASS (35). Proteins quantified with
at least three peptides were used for increased stringency.
Protein expression values of each of the two patients were
used to calculate probability that a given protein is expressed
similarly to healthy donors. Finally, proteins were sorted by
increasing probability of having a healthy expression value.
Proteins with assigned probability 0.01 were used for more
detailed manual inspection.
Sanger Sequencing—Patient DNA was extracted from full
blood samples with Qiagen DNeasy blood and tissue Kit
(Qiagen, Hilden, Germany, catalog number 69504). PCR re-
action was performed using OneTaq DNA polymerase kit
(New England Biolabs, Frankfurt a.M., Germany, catalog num-
ber M0480X), all with the same cycler conditions (5: 95°, 30”:
95°, 30”: 55°, 45”: 72°, 5: 72°). Before sequencing samples
were treated with Illustra ExoProStar (Merck, Darmstadt, Ger-
many, catalog number US78220) for removal of primers and
dNTP. Sequencing was performed by Eurofins Genomics
Germany, data were analyzed using SeqMan Pro of the
DNAstar software suite. The primers for ELANE were de-
signed in-house, whereas the primers for RAB27a were kindly
provided by Meeths et al. (36). The complete list of sequenc-
ing primers can be found in the supplemental Table S7.
Whole Exome Sequencing—High throughput sequencing
was performed by NextSeq500 with 2  150 bp reads. The
exomes were enriched using SureSelect Human All Exon Kit
Agilent V6UTR. BWA (37) (version 0.7.15) algorithm for short
Illumina reads was used to align the short reads to the human
reference genome GRCh37. The Genome Analysis Tool Kit
(38) (GATK version 3.6) was used for analysis of the whole
exome sequencing data. All algorithms and parameters were
chosen according to the GATK best practice pipeline. Func-
tional Annotation was performed with the Variant Effect Pre-
dictor (39) (VEP version 85). Final variants were filtered with a
custom database encompassing gnomAD (40) and GME (41)
following a rare homozygous and compound heterozygous
inheritance. SIFT (42) and PolyPhen-2 (43) were used as pro-
vided by VEP.
RNA Sequencing—Neutrophils from 22 healthy donors
were isolated using the same approach as for the proteomics
samples. RNA was isolated with the RNAeasy plus mini-kit
from Qiagen (catalog number 74134) according to the vendor
protocol. Magnetic oligo-dT beads (NEB) were used for
mRNA enrichment starting with 1 to 10 ng total RNA with RIN
values above 9. The NEBNext Ultra II directional RNA Library
prep Kit (NEB) was used to prepare RNA-seq libraries accord-
ing to the manufacturer’s protocol. Paired-end sequencing
was performed with 2 75 cycles on an Illumina NextSeq 500
(Care-for-Rare Genomics Facility at the Dr. von Hauner Chi-
ldren’s Hospital). The short reads were aligned with STAR (44)
version 2.5.0a to the human reference genome GRCh37.p13
with basic two-pass method. The counts were then generated
using the featureCounts program from the subread toolkit (45)
version 1.5.1. The counts were normalized for sequencing
depth and RNA type using DESeq2 (46). Median transcripts-
per-million (TPM) values were calculated by normalizing the
median gene read counts to the length of the union of all
possible exons coded by a given gene. The raw RNAseq data
have been deposited into Gene Expression Omnibus (47)
(GEO) under accession number GSE118644.
Gene Ontology Term Enrichment Analysis—The GO term
enrichment was performed using DAVID (48) online tool using
proteins quantified in the healthy neutrophils as background.
The GO BP DIRECT terms were used for analysis.
Data Analysis and Plotting—All data were analyzed using R
3.4 and plotted using ggplot2 R package (49). Differential
protein expression analysis was performed using the limma R
package (24). Single-patient protein expression anomaly de-
tection was performed using R MASS package (54).
RESULTS
Proteome Analysis of High-purity Neutrophil Samples—
First, we set up an experimental flow allowing for consistent,
robust, and reliable analysis of purified neutrophil granulo-
cytes. Using magnetic-bead based negative selection we iso-
lated neutrophil granulocytes with 99% purity from 16 pa-
tients with quantitative or qualitative defects (supplemental
Table S1) and 68 healthy control individuals (Fig. 1A, 1B).
Although 14/16 patients had a genetically confirmed molecu-
lar diagnosis of neutrophil deficiency (CGD: n 	 5, SCN: n 	
6, LAD: n 	 3), in two patients (one with NADPH-oxidase
deficiency, one with congenital neutropenia associated with
albinism) routine genetic workup by exome sequencing did
not yield a specific defect in any gene known to cause con-
genital neutropenia or CGD. A set of 4154 proteins was quan-
tified across all samples using data-independent acquisition
(DIA) mass spectrometry and neutrophil-specific spectral li-
braries generated by us. The estimated protein copy numbers
per cell using the proteomic ruler approach (50) and the full list
of quantified proteins in each sample are reported in the
supplemental Table S2. To estimate the variability in protein
expression measured by our approach, we compared pro-
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teomes of the same healthy individual sampled over three
different timepoints spanning several months. As expected
from DIA proteomics (51), we observed a high level of agree-
ment among replicates with a mean Pearson correlation co-
efficient of 0.87 (Fig. 1C). After correcting for batch effects
related to sample processing using the ComBat algorithm
(52), we looked at the separation of neutrophil proteomes of
healthy donors and patients using principal component anal-
ysis (PCA) (Fig. 1D). The groups were clearly separated along
the two first principal components, explaining in total 17%
of the total variability in the data.
Neutrophil mRNA Levels Are Not Well Correlated with Pro-
tein Levels—Next, we looked at correlation of protein expres-
sion with expression levels of the respective mRNAs in the
healthy naive neutrophils. We sequenced the transcriptomes
of 22 healthy donor neutrophil samples and compared cumu-
lative protein and protein-coding transcriptome abundances
(Fig. 2A). Interestingly, only seven proteins accounted for 50%
of the total protein copy number. This suggests that the
neutrophil proteome is dominated by a very few highly ex-
pressed proteins, with the antimicrobial proteins DEF3A,
S100A8, LYZ, and CTSG being among the most abundant. A
similar dynamic range can be seen for the protein-coding
transcriptome (top three abundant transcripts: MYCBP,
KIF2C, ATP6V0B). However, the top expressed protein-cod-
ing transcripts did not correspond to the top expressed pro-
teins (Fig. 2B, 2C). The healthy donor neutrophil mRNA abun-
dances were reported in supplemental Table S3.
We found no correlation between mRNA and protein levels
(Pearson correlation coefficient of 0.00; Fig. 2D). This result is
in sharp contrast to correlation coefficients obtained in other
cells, which typically range from 0.4 to 0.8 (53, 54) and
agrees with previous observations (13, 16, 55). Naive neutro-
phils have been shown previously to have reduced transcrip-
tional activity (56). It is therefore possible that the naive neu-
trophil transcriptome is not reflective of its function, but rather
prepared to initialize gene expression programs on activation,
as suggested by (56).
For this reason, we focused on in-depth analysis of pro-
teome rather than transcriptome data.
Differential Protein Expression in Neutrophil Granulocytes
from Patients with Monogenic Diseases—We asked the ques-
tion to what extent the composition of the proteome differed
among patients with severe congenital neutropenia because
of mutations in ELANE and healthy individuals. As shown in
Fig. 3A, the proteome of ELANE-mutated neutrophil granulo-
cytes showed 71 significantly underexpressed and 159 over-
expressed proteins. As expected, ELANE was one of the most
underexpressed proteins (4.5-fold). In addition, other primary
granule antimicrobial proteins, such as azurocidin (AZU1, 4.5-
fold) and cAMP receptor protein (CAMP, 5-fold) were also
markedly underexpressed. In the group of significantly over-
expressed proteins, we identified several endoplasmic retic-
ulum (ER) heat-shock proteins (DNAJB1, HSP90B, HSPA5,
HYOU1, SDF2L1, PDIA4, MANF), indicative of proteostatic
stress response. Another prominent group of significantly
overexpressed proteins were ribosomal proteins (RPL9,
RPL10, RPL11, RPL19, RPL21, RPL22, RPL31, RPL32,
RPL38, RPS23) and mitochondrial proteins (SPTLC2,
ABCB10, EIF2A. LRPPRC, CYCS, SLC25A1, LONP1, PUS1,
LETM1, TOMM22, GRPEL1, HSPA9, SHMT2). Several tran-
scription factors were differentially expressed (decreased lev-
FIG. 1. Mass spectrometry-based workflow for neutrophil proteome profiling. A, Neutrophil granulocyte samples were extracted from
peripheral blood of healthy donors and patients, purified and subjected to data-independent acquisition mass spectrometry. B, Flow cytometry
showed high neutrophil purity (99%) after isolation. C, Pearson correlation analysis of samples from the same individual obtained at three
different timepoints shows high level of correlation among biological replicates. PCC, Pearson correlation coefficient. D, Principal component
analysis demonstrates good separation of healthy and diseased individuals using full protein expression profiles.
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els: TCEAL3, ZNF22, increased levels: LRPPRC, SND1). It is
currently not known whether this reflects differences in mat-
uration stages or a specific response to the disturbed subcel-
lular environment in ELANE-mutated neutrophil granulocytes.
Fig. 3B shows the relative abundance of the top 6 proteins
with the most significantly changed expression values. The
most enriched Gene Ontology (GO) Biological Process (BP)
terms among the up-regulated proteins were “translational
initiation” (adj. p value: 9.8  1011), “nuclear-transcribed
mRNA catabolic process, nonsense-mediated decay” (adj. p
value: 2.8  105) and “protein folding” (adj. p value: 8.3 
104). The most significant BP term enriched among down-
regulated proteins was “proteolysis” (adj. p value: 5.6 
102), a term which encompasses the neutrophil antimicrobial
proteins like ELANE and AZU1. In contrast to the proteome of
ELANE-mutated neutrophil granulocytes, the analysis of neu-
trophil granulocytes from CGD patients (n	 5) revealed fewer
striking differences when compared with healthy individuals
(Fig. 3C). Interestingly, the two proteins with the lowest ex-
pression levels were CYBA and CYBB (down-regulated 16-
fold and 84-fold, respectively). This suggests that mutations in
either CYBA or CYBB are destabilizing the membrane-
bound heterodimeric complex, whereas the expression of
the three cytosolic members of the NADPH-oxidase com-
plex (NCF1, NCF2, NCF4) is not affected (supplemental Fig.
S1). Several secondary granule proteins, such as CAMP,
LTF, and CRISP3, were also decreased in abundance, albeit
to a lower degree. The most enriched GO BP terms among
the upregulated proteins in CGD were: “type I interferon
signaling pathway” (adj. p value: 4.4  1011), “defense
response to virus” (adj. p value: 1.3  107) and “comple-
ment activation, classical pathway” (adj. p value: 1.1 
102). The most significant BP term enriched among down-
regulated proteins in CGD was: “cell redox homeostasis”
(adj. p value: 2.1  102) which encompasses the affected
proteins CYBA and CYBB together with CAMP and LTF. The
proteomes of patients with LAD (2 ITGB1, 1 GFTP/
SLC35C1) were minimally disturbed when compared with
healthy individuals and showed ITGB2 and related members
of the integrin family (ITGAM, ITGAX, ITGAL) as proteins
with strongest underexpression. Moreover, the antimicro-
bial protein CRISP3 was found to be expressed at lower
levels than controls (supplemental Fig. S2). No GO BP terms
were enriched among the up-regulated proteins in LAD. The
most enriched GO BP terms among the downregulated
proteins in LAD were: “integrin-mediated signaling path-
way” (adj. p value: 7.6  104), “leukocyte migration” (adj.
p value: 7.1  104), “extracellular matrix organization” (adj.
p value: 2.0  103) and “cell adhesion” (adj. p value: 1.8 
102). All differentially expressed proteins have been re-
ported in the supplemental Table S4.
Comparison of Protein Expression Profiles of SCN, CGD,
and LAD—We compared the similarity of differentially ex-
pressed proteins in SCN-ELANE, CGD, and LAD (Fig. 3G). As
expected, most of the patient samples clustered together
according to their clinical phenotypes. There was however
one exception: the one LAD2 (SLC35C1) sample was clus-
tered with the SCN group owing to its different genetic back-
ground than the two LAD1 cases and protein expression
changes more resembling SCN cases than LAD1.
In the heatmap one can observe multiple distinct protein
clusters. One prominent cluster of proteins was the interferon
1-response pathway (STAT2, MX1, MX2, TRIM22, IFIT3),
overexpressed in four CGD cases, one LAD1 case and one
SCN case, but mostly unchanged in other SCN cases and the
other two LAD cases. All patient neutrophils showed under-
expression of granule proteins (CAMP, CRISP3, AZU1), with
SCN cases exhibiting the strongest difference. Finally, a
prominently underexpressed CYBA/CYBB (flavocytochrome
b558) cluster of four CGD cases can be observed, with the
fifth CGD case demonstrating very minimal underexpression
of those proteins. Next, we directly compared all significantly
over- and underexpressed proteins of the three clinical phe-
notypes for overlaps (Fig. 3H). Overall, we observe only min-
FIG. 2. Protein and transcript expression profiles in healthy neutrophils. A, Cumulative abundances of proteins and protein-coding
transcripts follow a similar pattern. Only seven proteins account for50% of the total protein copy number in neutrophils. B, Top 10 expressed
protein-coding transcripts in healthy donor neutrophils. TPM, transcripts per million; CV, coefficient of variation. C, Top 10 expressed proteins
in healthy donor neutrophils. CV, coefficient of variation D, We observed no correlation (PCC 	 0.00) of transcriptome and proteome in healthy
naive neutrophil granulocytes. PCC, Pearson correlation coefficient.
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FIG. 3. Differential protein expression in SCN, CGD and LAD. A, Volcano plot illustrating changes in neutrophil granulocyte protein expression
between SCN-ELANE (n 	 6) and healthy individuals (n 	 68). X-axis showing log2 fold change compared with healthy control, Y-axis showing
-log10(p value). A total of 71 proteins were significantly underexpressed in ELANE-mutant cells, 159 were significantly overexpressed. Points
marked in orange have adjusted p values 0.01 and absolute fold-change 2. B, Top six significantly differentially expressed proteins in SCN,
ordered by decreasing mean estimated log10 copy number. The differentially expressed proteins span four orders of magnitude of abundance. C,
Differential protein analysis of CGD cases versus healthy individuals. The most downregulated proteins are members of the flavocytochrome b558
complex affected in CGD, namely CYBA and CYBB. Interferon-1-responsive network members (MX1, MX2, STAT2) were significantly up-regulated
in CGD. Points marked in orange as in Fig. 3A. D, Top six significantly differentially expressed proteins in CGD, ordered by decreasing mean
estimated log10 copy number. E, Differential protein analysis of LAD cases versus healthy control. Only modest proteome-level effects could be
detected. The most downregulated proteins were integrins which are members of the affected protein family (ITGB2, ITGAM, ITGAX). F, Top six
significantly differentially expressed proteins in LAD, ordered by decreasing mean estimated log10 copy number. G, Heatmap of protein expression
DIA Proteomics Aids Clinical Genetic Diagnostics
766 Molecular & Cellular Proteomics 18.4
 by guest on A
pril 1, 2019
http://w
w
w
.m
cponline.org/
D
ow
nloaded from
 
imal overlap of significantly dysregulated proteins between
the three diseases.
Proteome Analysis Guiding Molecular Diagnosis—Two pa-
tients in our cohort had clinical signs and symptoms of neu-
trophil granulocyte deficiency (one patient with CGD con-
firmed by negative nitro blue tetrazolium (NBT) test and one
patient with congenital neutropenia associated with albinism)
but exome sequencing analyses did not yield a molecular
diagnosis. We therefore analyzed proteomes of those cases
and fitted Gaussian models for each protein using the expres-
sion data in 68 healthy samples. Next, we calculated the
likelihood that a given expression value in a patient sample
could come from the healthy distribution. Finally, we plotted
the copy number values for the top ten dysregulated proteins
for each case (Fig. 4A, 4B). The lists of significantly affected
proteins and their copy numbers have been reported in the
supplemental Table S5.
Fig. 4A shows the ten most anomalous protein expression
values of neutrophil granulocytes in the CGD patient, with
the most pronounced down-regulation of NCF1. Molecular
diagnosis of NCF1 deficiency is challenging, because the
human genome contains two NCF1-pseudogenes with 99%
sequence homology. Using gene- and pseudogene-specific
probes (57), two normal NCF1 alleles and four NCF1 pseu-
dogene alleles could be detected in healthy control cells,
but only pseudogenes could be detected in patient CGD6
(Fig. 4C). This shows that proteome analysis in neutrophil
granulocytes could be used as a pre-screening procedure
to classify patients for specific NCF1 sequencing.
Patient SCN7, a 1-year old boy born to consanguineous
parents, had immunodeficiency with recurrent infections of
skin and the upper respiratory tract, oral ulcerations, spleno-
megaly and chronic diarrhea, associated with partial albinism.
He had intermittent congenital neutropenia and pancytopenia.
Proteome analysis of his neutrophil granulocytes revealed a
marked decrease of RAB27A protein expression (Fig. 4B).
Sanger sequencing of the RAB27a gene confirmed a segregat-
ing homozygous mutation (NM_004580.4(RAB27A): c.148_
149delinsC) in the patient (Fig. 4D) and thus established the
diagnosis of Griscelli syndrome (58). Of interest, this patient also
showed underexpression of SYTL1, a known binding partner of
RAB27A (59).
DISCUSSION
In this study, we looked at neutrophil proteome changes
in patients with monogenic diseases. We show that pro-
teomics is helpful in establishing genetic diagnosis in neu-
trophil deficiencies in cases where routine genetic testing is
not conclusive.
Other laboratories have reported data on the proteome of
human neutrophil granulocytes (10–23). Rieckmann et al.
studied the proteomes of leukocyte subpopulations and re-
ported quantitation data for 6007 proteins in naive neutrophil
granulocytes using a data-dependent acquisition method op-
timized for depth and using TrEMBL protein annotation. Our
data-independent approach was aimed at rapid and precise
quantification of proteins in a large number of samples and
relied on manually curated Swiss-Prot annotation. We ob-
served a moderate level of correlation of our estimated protein
copy numbers with the Rieckmann et al. data (PCC 	 0.7).
Moreover, we overcame past problems from endogenous
proteases in neutrophils causing extensive sample degrada-
tion by enhancing the neutrophil sample handling conditions.
This resulted in primarily tryptic peptides which improved
reliable protein identification and quantitation. The crucial fac-
tor for this improvement seems to be the use of high amounts
of protease inhibitors shortly after sample collection.
Our RNAseq data showed high agreement (PCC 	 0.85)
with publicly available data (56). Interestingly, there was no
correlation between protein and mRNA levels in our healthy
neutrophil samples (PCC 	 0.00), which prompted us to
focus our analytical efforts on proteome changes rather
than transcriptome changes, as the former is closer related
to function (60, 61). This also suggests that clinical neutro-
phil diagnostics should be rather focused on protein expres-
sion analysis than transcriptomics. However, we did not
analyze the transcriptomes of patients. There is a possibility
that in some cases, such as monogenic diseases affecting
the maturation of neutrophils, the correlation between the
proteome and the transcriptome is higher and, in those
cases, using transcriptomics for clinical diagnostics could
be beneficial.
We looked at protein expression profiles of three rare
monogenic diseases of neutrophil granulocytes. The largest
differences could be observed for the SCN cases. This dis-
ease affects the maturation of neutrophils by the mislocalized
protease ELANE, leading to increased proteostatic stress
within the cell (62). Indeed, we observe an overexpression of
the heat-shock response systems which might be an effect of
many misfolded proteins within the cell. Increased expression
of ribosomal and mitochondrial proteins may be related to the
immature phenotype of SCN-affected neutrophils observed in
our cytospin controls. We observed decreased expression of
proteins in all granule subsets in SCN neutrophils, indicating
levels in all analyzed cases normalized to expression in healthy individuals and z-transformed within each sample. Samples and proteins were
ordered using hierarchical clustering. Dendrograms show relative Euclidean distances between samples or proteins. Samples tend to be
clustered close together as expected by genetic analysis, except for the one LAD2 case. Very homogenous expression profiles can be seen
for the six SCN samples and four CGD samples. CYBB*, CYBB splice donor variant. H, Venn diagram comparing differentially expressed
proteins in SCN-ELANE, CGD, and LAD (note the low degree of overlap between diseases).
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antimicrobial deficiency beyond reduced cell numbers. This
further expands the results of a previous study that analyzed
neutrophils of genetically undetermined SCN patients and
showed loss of alpha defensins and LL37 (63).
Reduced LL37 (CAMP) level in serum was proposed as a
marker for SCN patients, potentially differentiating it from
autoimmune neutropenia by indicating faulty granulopoiesis
(64). We confirmed the observation of CAMP underexpres-
sion in neutrophils of ELANE patients but also showed
CAMP underexpression in CGD neutrophils. This warrants
caution to the claim that low CAMP levels always indicate
disturbance of granulopoiesis.
The proteome changes in the CGD cases were more local-
ized, affecting mostly the protein complex affected by the
mutations (flavocytochrome b558) and other proteins local-
ized in secondary granules. In the supplemental Fig. S1 we
plotted expression of all neutrophil NADPH oxidase members.
Patients with CYBA and CYBB mutations have low expression
FIG. 4. Proteome analysis guiding molecular diagnosis. A, Top 10 deregulated proteins in patient CGD6. B, Proteome deregulation
analysis for the other neutropenia case without known genetic mutation. The protein-level analysis found a significant underexpression of
RAB27A protein (by two orders of magnitude) and its interaction partner, SYTL1. C, Gene-scan analysis using gene- and pseudogene-specific
fluorescent primers in patient CGD6. Note two normal NCF1 alleles (product size 204 bp) and 4 NCF1 pseudogene alleles (product size 202
bp) in a healthy control which result in the physiologically normal 2:1 signal ratio. In patient CGD6, only 4 pseudogene alleles but no normal
NCF1 alleles are present. DNA-free water served as a negative control. D, Sanger sequencing of the RAB27a gene in patient SCN7 and his
mother revealed a homozygous mutation in exon 2 (NM_004580.4(RAB27A):c.148_149delinsC) in the patient. The patient’s mother was a
heterozygous carrier of the mutation.
DIA Proteomics Aids Clinical Genetic Diagnostics
768 Molecular & Cellular Proteomics 18.4
 by guest on A
pril 1, 2019
http://w
w
w
.m
cponline.org/
D
ow
nloaded from
 
of both proteins as has been observed before (65) with no loss
of other complex members. It is known that CGD patients
suffer from a state of hyperinflammation, but the molecular
mechanism has not yet been identified. We did not observe
any overexpression of inflammatory mediators and inducers
in CGD nor did we see dysregulation of TLRs as mentioned in
a previous study (66). One of the LAD cases with ITGB2
mutation also shows an overexpression of the IFN1 response
network. Clinically the patient was very sick which points at a
possibility of systemic hyperinflammation. We therefore as-
sumed that the IGN1 response network activation in the an-
alyzed neutrophil proteomes could be related to infection
rather than the underlying genetic causes. Analyzing the LAD
cases as single samples, we note that proteins with lowest
expression levels in LAD1 (ITGB2 mutation) were the integrins
ITGB2, ITGAM and ITGAX whereas in LAD2 (SLC35C1 muta-
tion) integrin expression was not affected.
Of interest, one of the CGD patients (CGD1) with a splice
site mutation showed a protein expression pattern like both
CGD and SCN, with milder underexpression of CYBA and
CYBB but with substantial underexpression of NCF1 (supple-
mental Fig. S1). Interestingly, the patient has the same splice
site mutation as another CYBB case in our cohort (CGD3) but
in addition to immunodeficiency and lack of respiratory burst
reaction, shows low absolute neutrophil counts (ANC 500–
1400/l) and a severe neurological phenotype with mental
retardation and facial dysmorphia. A polygenic etiology must
be suspected, potentially altering his neutrophil proteome in
additional ways. An NCF1 mutation in the patient was ex-
cluded by the Gene-scan method (communicated by the
treating physician, data not shown). We also excluded Wil-
liams Beuren Syndrome, very rarely associated with CGD (67)
and found no mutation in XL, thereby excluding McLeod
syndrome. The elucidation of causes of the underlying dis-
ease warrants a follow-up study.
Finally, data-independent acquisition proteomics helped us
guide genetic diagnostics of cases for which standard exome
sequencing did not provide clear answers. The observed
NCF1 underexpression was a clear hint for the underlying
molecular mechanism of the disease as 20% of CGD patient
cases are caused by NCF1 mutations. Sequencing efforts for
NCF1 are known to be complicated by two pseudogenes
sharing 99% homology. A commercially available solution
using a published Gene-scan method (68) can circumvent this
problem. However, this is a costly method if applied to all
patients. Our proteomics results allowed us to narrow-down
the most likely cause of the disease and could be confirmed
using the Gene-scan method.
The second case with inconclusive exome sequencing was
a patient with neutropenia and partial albinism. Proteomics
allowed us to guide genetic analysis and suggested RAB27A
protein as the possible cause. Mutations in RAB27a are
known to cause Griscelli 2 syndrome, matching well with the
patient’s phenotype. Sanger sequencing of RAB27a exons
demonstrated a homozygous mutation in exon 2. Indeed,
Sanger sequencing and whole exome sequencing confirmed
that the patient’s mother was heterozygous for this mutation.
When we compared the exome result of patient and mother,
it became apparent, that in the patient the last part of exon 2
was not covered by the sequencing reads, explaining why we
could not detect his mutation initially.
Mass spectrometry is a powerful technique for parallel
quantitation of thousands of proteins. Its true potential is
only being revealed in the clinical setting. Neutrophils are
cells that are hard to work with for molecular diagnostics as
they contain numerous highly abundant proteases and
RNAses leading to quick degradation of their contents. We
presented here a workflow for high purity and high-quality
neutrophil proteome samples acquired by state-of-the-art
DIA mass spectrometry which allows for quick profiling of
neutrophils (1.5 days of sample preparation plus 130 min
per sample acquisition time). We believe that this approach
can be further used to aid in genetic and clinical diagnosis
of neutrophil diseases and expand our knowledge of the
neutrophil biology itself.
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